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BRIEF COMMUNICATION
EPSTEIN BARR VIRUS DETECTION IN CERVICAL SAMPLES OF WOMEN LIVING WITH HUMAN 
IMMUNODEFICIENCY VIRUS
Ledy H.S. OLIVEIRA, Larissa S. SANTOS & Fernanda G. NOGUEIRA
SUMMARY
Epstein Barr Virus (EBV) is transmitted commonly by saliva, but it has been found in genital secretions, which suggests sexual 
transmission and led researchers to connect EBV and cervical neoplasia. People living with human immunodeficiency virus (HIV) 
are reported to be at high risk of acquiring genital infections and cervical lesions. To verify the presence of EBV in the genital tract 
and/or it could affect cervical changes, we analyzed cervical smears from 85 HIV seropositive women for EBV DNA determination. 
EBV was only detected in two (2.3%) samples. The present study provides neither evidence for EBV as sexually transmitted infection 
nor discards this possibility.
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INTRODUCTION
Epstein Barr Virus (EBV) is a ubiquitous microorganism causing 
widespread infection worldwide. Most of EBV infected people (reaching 
90% of humans) are lifelong asymptomatic carriers but the risk of diseases 
and malignancies linked to this virus increases in immune-compromised 
patients4. Human immunodeficiency virus (HIV) is commonly associated 
with activation and widespread of several pathogens including EBV16. 
The HIV, among other causes for immune-deficient status, enhances the 
deleterious potential of this infectious agent3.
EBV is transmitted commonly by saliva, but it has been found 
in genital secretions suggesting that sexual transmission may occur9. 
WOODMAN et al.18 have reported that the acquisition of EBV infection 
is associated with the sexual behavior of young women. Other studies, 
however, indicate that the EBV sexual transmission is not sufficiently 
established. EBV could occasionally be transmitted by a sexual route, 
but the detection of the virus in genital secretions could reflect the 
infected stromal lymphocytes15. On the other hand, some reports show 
a connection between EBV and cervical changes7, but again, the role 
of this virus in the development of cervical neoplasia is also not clear. 
SHOJI et al.12 performed a in situ hybridization assay to show that the 
detection of EBV in cervical neoplasia was dependent on the degree of 
lymphocyte infiltration and therefore, the virus was not implicated in the 
etiology of cervical neoplasia.
Once HIV infected, people have more chance of acquiring pathogen 
agents as well as developing clinical symptoms, and in view of 
contradictory reports described above, we undertook a study to detect 
EBV infection in cervical smears from HIV positive women through 
conventional and nested polymerase chain reaction (PCR).
 
MATERIAL AND METHODS
A cross-sectional study included cervical samples from 85 HIV 
infected women collected between 2003 and 2005. Patients were referred 
to the Cervical Pathology Service of the Hospital dos Servidores do 
Estado (HSE), Rio de Janeiro, Brazil. They were screened according 
to the routine schedule among female patients from an AIDS reference 
hospital. Samples for routine Papanicolaou exam were collected after 
colposcopic examination. According to the Bethesda nomenclature 
cervical lesions were classified as Normal, atypical squamous cells of 
undetermined significance (ASCUS), low grade squamous intraepithelial 
lesions (LSIL), or high grade squamous intraepithelial lesions (HSIL)14. 
Demographic, behavior and data related to HIV infection were obtained 
through a structured questionnaire. The Ethics Committee of the College 
of Medicine at the University approved the protocols for collection and 
for informed consent.
DNA was extracted from samples either with phenol-chloroform 
method or by a commercial assay kit (Invisorb, Uniscience). EBV 
detection and typing were performed by generic and nested PCR 
respectively. For EBV DNA, the following primers were used: E2P1: 
5’-AGG GAT GCC TGG ACA CAA GA-3’ and E2P2: 5’-TGG 
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TGC TGC TGG TGG TGG CAA T-3’. They amplify a 596 pb DNA 
sequence specific for EPB E2 ORF5. Amplification was developed in 
a 50 mL reaction mixture (1x PCR buffer, 200 mM dNTPs, 1.5 mM 
MgCl
2
, 50 pmol of each primer, 0.25 U unit of Taq polymerase, and 
5 mL of sample) with 40 cycles of amplification. Each cycle included a 
denaturizing step at 94 °C for 30 seconds, an annealing step at 58 °C for 
seconds, and a chain elongation step at 72 °C for 60 seconds using DNA 
Thermal Cycler (Pekin Elmer, CETUS). Absence of DNA inhibitors was 
checked by b-actine primers (0.1 pmol each) for amplifying a 330 bp 
region of the human DNA as internal control. Polymerase chain reaction 
(PCR) products were analyzed on 1.5% agarose gel with ethidium 
bromide staining for visualization of DNA under ultraviolet light. The 
molecular weight of each sample was compared to 100 bp DNA ladder.
EBV-1 and EBV-2 typing - The nested-PCR was performed by inner 
amplification of 2 µL of the primary PCR products. The upstream and 
the downstream EBV-1 primers set were Ap1: 5’- TCT TGA TAG GGA 
TCC GCT AGG ATA -3’ and Ap2: 5’- ACC GTG GTT CTG GAC TAT 
CTG GAT C -3’ respectively, to amplify a 497 bp product. The EBV-
2 primers set were Bp1: 5’- CAT GGT AGC CTT AGG ACA TA -3’ 
and Bp2: 5’- AGA CTT AGT TGA TGC CCT AG -3’ resulting in an 
amplicon of 150 bp (Life technologies, Brazil). It was performed with 
25 cycles which consisted of steps at 94 °C for 30 seconds, 58 °C for 30 
seconds, and 72 °C for 45 seconds, and 72 °C for the final elongation 
step5. Positive and negative controls were also performed. To avoid false 
positive results, besides the standard controls, a tube containing extracted 
DNA negative to EBV was amplified with EBV primers. Nested-PCR 
products were analyzed on 1.5% agarose gel with ethidium bromide 
staining for visualization of DNA under ultraviolet light and checked 
by comparison with a 100-bp DNA ladder.
RESULTS
The features of the sample are shown in Table 1. The patients aged 
14-59 years, mean 31 years and standard deviation 8.37. All the patients 
had an active sexual life. Most of them had their first sexual experience 
before 17 years and three had lifetime sexual partners. Herpetic genital 
lesions were found in 23.7% of the patients. More than half of the patients 
(57.6%) had cervical lesions (Table 2). Almost all the patients (97.7%) 
were under antiviral treatment.
EBV was only detected in two (2.3%) samples. In view of the small 
number of EBV positive samples, it was not possible to infer a statistical 
analysis. However, they shared some common features. Both samples 
were obtained from women carrying nearly 500 CD4 cells/mL with the 
length of time since HIV diagnosis being more than four years, under 
antiviral treatment, having had five sexual partners and their first sexual 
intercourse before 17 years. Their partners were also HIV positive. One 
of them presented low-grade squamous intraepithelial lesion and was 
infected with EBV-2. The other, showing normal cytology, harbored 
EBV 1 and 2 as well as clinical genital herpes.
DISCUSSION AND CONCLUSIONS
Although the evidence of EBV infection in cervical scrapings has 
been reported by several researches6,11, other studies do not agree with 
these findings. ANDERSSON-ELLSTRÖM et al.2, investigating EBV 
DNA in the cervix of virgin teenage girls or those with their first sexual 
Table 1
Profile of 85 HIV positive women investigated for EBV infection
Variable No. (%)
Age
    ≤ 30 years 42 (49.4)
    > 30 years 43 (50.6)
Family income
    0-2 minimum salary 58 (68.2)
    > 2 minimum salary 15 (17.6)
Education level
    Illiterate, elementary school 38 (44.7)
    Less than high school 46 (54.1)
Ethinicity
    White 48 (56.5)
    Non white 37 (43.5)
Age of sexual debut
    ≤ 17 years 66 (77.6)
    > 17 years 19 (22.4)
Number of sexual partners
    > 3 55 (64.7)
    1-3 30 (35.5)
Alcohol use 
    Yes 27 (31.8)
    No 58 (68.2)
Smoking
    Yes 21 (24.7)
    No 64 (75.3)
Drug use
    Yes  7 (8.2)
     No 77 (90.6)
STD
    Yes 28 (32.9)
    No 57 (67.1)
Herpetic lesions
    Yes 19 (22.4)
    No 66 (77.6) 
HIV diagnosis time 
    ≤ 4 years 55 (64.7)
    > 4 years 30 (35.3)
CD4/mL count
    0-200 11 (12.9)
    > 200 74 (87.1)
HIV load 
    undetectable 43 (50.6)
    ≥ 80 copies/mL 42 (49.4)
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experience, concluded that the non-sexual route of EBV was more 
plausible than the sexual route.
Despite having studied an HIV positive sample, we detected a very 
low EBV frequency. Interestingly, the EBV 2 type was seen in both 
samples. It was also related with HIV seropositivity and an increased 
number of sexual partners, suggesting sexual transmission for this type17. 
Even though we cannot show an association between EBV positivity 
and other factors due to the small number of EBV infected people, both 
EBV infected women had behavior that risked sexual infections. Thus, 
the possibility of sexual transmission is higher.
In two HIV positive women survey, the EBV prevalence in the genital 
tract was 10% and 23% respectively1,13. Both studies did not find any 
link between EBV and cervical lesions. Even though we detected 12.9% 
of HSIL cases, none of them had cervical EBV DNA. So, EBV could 
occasionally be transmitted by the sexual route without risk to cervical 
lesions. On the other hand, PAYNE et al.10, studying cervical cancers 
in HIV negative people, did not find any EBV infection in squamous 
epithelial cells.
 Our results are similar to LANHAM et al.8. They found EBV DNA 
in only five out of 160 HIV negative women (3%). With regards to our 
findings (2.3%), HIV infection did not affect the frequency of EBV.
Finally, when we analyze the present study face to other reports, we 
can see that the spread of EBV by the sexual route remains inconclusive. 
Our findings do not provide evidence for EBV as a sexually transmitted 
infection but neither discard this possibility.
RESUMO
Detecção do vírus Epstein-Barr em amostras cervicais de 
mulheres infectadas pelo vírus da imunodeficiência humana
O vírus Epstein-Barr (EBV) é transmitido comumente pela saliva, 
mas pode ser encontrado também em secreções genitais, sugerindo 
transmissão sexual e levando pesquisadores a associar este vírus à 
neoplasia cervical. Pessoas infectadas pelo virus da imunodeficiência 
humana (HIV) são de alto risco para aquisição de infecções genitais 
e lesões de cérvice uterina. Com o objetivo de verificar a presença do 
DNA do EBV no trato genital e/ou se poderia ter efeito em alterações 
cervicais, analisamos esfregaços cervicais de 85 mulheres HIV 
soropositivas. O vírus foi detectado em apenas duas (2,3%) amostras. 
O presente estudo não fornece evidência da transmissão sexual do EBV, 
nem descarta esta possibilidade. 
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